Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data. [PDF]
Lupus Sci MedLin A +3 more
europepmc +1 more source
Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritis. [PDF]
Lupus Sci MedDrougkas K +15 more
europepmc +1 more source
Anti-CD19 monoclonal antibody for systemic lupus erythematosus and neuromyelitis optica spectrum disorder. [PDF]
Lupus Sci MedGonzalez Manrique P +3 more
europepmc +1 more source
Children exposed to hydroxychloroquine in utero show no signs of retinal toxicity at age 5. [PDF]
Lupus Sci MedIzmirly PM +7 more
europepmc +1 more source
Bullous Systemic Lupus Erythematosus: Clinical Presentation in Two Asian Cases. [PDF]
Case Rep MedNguyen PTT +4 more
europepmc +1 more source
Stress exposure prior to diagnosis and clinical characteristics in systemic lupus erythematosus: a cross-sectional study. [PDF]
Rheumatol IntPapachristodoulou E +8 more
europepmc +1 more source
Late-onset recurrent lupus nephritis in a kidney transplant recipient. [PDF]
Clin Nephrol Case StudCobb JK +5 more
europepmc +1 more source
Transitioning from invasive to liquid biopsy techniques: a bibliometric analysis and prospective insights on biomarkers in lupus nephritis. [PDF]
Front Med (Lausanne)Liu C +5 more
europepmc +1 more source